Qianjiang Yongan Pharmaceutical Co., Ltd. (SHE:002365)
China · Delayed Price · Currency is CNY 21.20
-0.66 (-3.02%)
Aug 15, 2025, 2:45 PM CST
Qianjiang Yongan Pharmaceutical Company Description
Qianjiang Yongan Pharmaceutical Co., Ltd. engages in production and sale of taurine in China.
It produces ethylene oxide, polycarboxylic acid-based water reducer monomers, water reducers, and health products.
The company engages in scientific research and technical service, creatine monohydrate, wholesale and retail trade, leasing and business services, and crop farming.
Qianjiang Yongan Pharmaceutical Co., Ltd. was founded in 2001 and is based in Qianjiang, China.
Qianjiang Yongan Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 2001 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 930 |
| CEO | Rengui Hong |
Contact Details
Address: No. 2 Guangze Avenue Qianjiang, 433132 China | |
| Phone | 86 72 8620 4039 |
| Website | chinataurine.com |
Stock Details
| Ticker Symbol | 002365 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000LZ9 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Rengui Hong | MD and Director |
| Shengjie Xiong | Chief Financial Officer and Secretary |
| Zidi Chen | Executive Vice President and Non-Independent Director |
| Xiquan Fang | Deputy General Manager |
| Zhihua Wang | Deputy General Manager |
| Shaobo Li | Senior Management |
| Wei Ye | Deputy General Manager |
| Tianyuan Zhang | Accounting Supervisor |